Cargando…

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome

BACKGROUND: Schistosomiasis is a neglected tropical disease burdening millions of people. One drug, praziquantel, is currently used for treatment and control. Clinically relevant drug resistance has not yet been described, but there is considerable heterogeneity in treatment outcomes, ranging from c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneeberger, Pierre H. H., Coulibaly, Jean T., Panic, Gordana, Daubenberger, Claudia, Gueuning, Morgan, Frey, Jürg E., Keiser, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848565/ https://www.ncbi.nlm.nih.gov/pubmed/29530088 http://dx.doi.org/10.1186/s13071-018-2739-2

Ejemplares similares

Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial
por: Coulibaly, Jean T, et al.
Publicado: (2017)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
por: Panic, Gordana, et al.
Publicado: (2015)

Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota
por: Schneeberger, Pierre H.H., et al.
Publicado: (2018)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial
por: Coulibaly, Jean T., et al.
Publicado: (2018)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara, Rokaya O, et al.
Publicado: (2018)

Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni
por: Buchter, Valentin, et al.
Publicado: (2021)

Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion
por: Olliaro, Piero L., et al.
Publicado: (2015)

In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections
por: Lamberton, Poppy H. L., et al.
Publicado: (2010)

Evaluation of the Clinitek®, a point-of-care urinalysis system for the measurement of clinically significant urinary metabolites and detection of haematuria in Schistosoma haematobium infected children in southern Côte d’Ivoire
por: Panic, Gordana, et al.
Publicado: (2019)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
por: Pinto-Almeida, António, et al.
Publicado: (2016)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure
por: McCusker, Paul, et al.
Publicado: (2021)

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection
por: Nono, Justin Komguep, et al.
Publicado: (2021)

Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection
por: Kadji Fassi, Joseph Bertin, et al.
Publicado: (2022)

Effect of Maternal Schistosoma mansoni Infection and Praziquantel Treatment During Pregnancy on Schistosoma mansoni Infection and Immune Responsiveness among Offspring at Age Five Years
por: Tweyongyere, Robert, et al.
Publicado: (2013)

The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni
por: Viana, Mafalda, et al.
Publicado: (2017)

Complementary Effect of Capparis Spinosa L. and Silymarin With/without Praziquantel on Mice Experimentally Infected with Schistosoma Mansoni
por: El-Hawary, S. S., et al.
Publicado: (2018)

Naturally Occurring Cardenolides Affecting Schistosoma mansoni
por: Keiser, Jennifer, et al.
Publicado: (2020)

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni
por: Gouveia, Maria João, et al.
Publicado: (2019)

Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda
por: Kabatende, Joseph, et al.
Publicado: (2023)

Chemometric analysis of biofluids from mice experimentally infected with Schistosoma mansoni
por: Li, Jia V, et al.
Publicado: (2011)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies
por: Coulibaly, Jean T, et al.
Publicado: (2013)

Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)
por: Hoekstra, Pytsje T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g67cgkd7mk460i9k2rk57nihh9